Lauren Coyle(Editor, BioInsights)speaks withLonza'sLaura Sands(Head of Regulatory Affairs), Ramesh Koukuntla(Director of R&D), Wenling Dong (Head of Upstream Process Development), and Vijetha Bhat (Subject Expert of Platform Technologies) about:
Key regulatory considerations when transitioning to AAV producer cell lines
Comparability and bridging strategies to support a successful transition
Approaches to managing manufacturing and regulatory risk
Considerations for enabling scalable AAV production
Podden och tillhörande omslagsbild på den här sidan tillhör
BioInsights. Innehållet i podden är skapat av BioInsights och inte av,
eller tillsammans med, Poddtoppen.
